

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug catabolic process (GO:0042737) | 9.72536182 |
| 2 | regulation of fibrinolysis (GO:0051917) | 7.90987279 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.79031517 |
| 4 | negative regulation of fibrinolysis (GO:0051918) | 7.74150682 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 7.67490980 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58128766 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 7.58128766 |
| 8 | glyoxylate metabolic process (GO:0046487) | 7.56354459 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 6.80577337 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.80577337 |
| 11 | regulation of protein activation cascade (GO:2000257) | 6.65082715 |
| 12 | complement activation, alternative pathway (GO:0006957) | 6.53720957 |
| 13 | cellular glucuronidation (GO:0052695) | 6.51354181 |
| 14 | oxidative demethylation (GO:0070989) | 6.46793189 |
| 15 | fibrinolysis (GO:0042730) | 6.41270884 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 6.38217324 |
| 17 | regulation of complement activation (GO:0030449) | 6.27404635 |
| 18 | uronic acid metabolic process (GO:0006063) | 6.20184241 |
| 19 | glucuronate metabolic process (GO:0019585) | 6.20184241 |
| 20 | drug metabolic process (GO:0017144) | 6.06033407 |
| 21 | bile acid biosynthetic process (GO:0006699) | 5.91478071 |
| 22 | negative regulation of sterol transport (GO:0032372) | 5.89986423 |
| 23 | negative regulation of cholesterol transport (GO:0032375) | 5.89986423 |
| 24 | urea metabolic process (GO:0019627) | 5.85496879 |
| 25 | protein carboxylation (GO:0018214) | 5.74802351 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.74802351 |
| 27 | ethanol oxidation (GO:0006069) | 5.66449242 |
| 28 | blood coagulation, intrinsic pathway (GO:0007597) | 5.51724290 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 5.46211983 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 5.31629375 |
| 31 | indolalkylamine catabolic process (GO:0046218) | 5.31629375 |
| 32 | tryptophan catabolic process (GO:0006569) | 5.31629375 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.31214282 |
| 34 | phenylpropanoid metabolic process (GO:0009698) | 5.31123392 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 5.30288608 |
| 36 | bile acid metabolic process (GO:0008206) | 5.29738595 |
| 37 | S-adenosylmethionine metabolic process (GO:0046500) | 5.20586804 |
| 38 | regulation of plasminogen activation (GO:0010755) | 5.03575557 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.87602436 |
| 40 | alkaloid metabolic process (GO:0009820) | 4.84825686 |
| 41 | glycine metabolic process (GO:0006544) | 4.81737098 |
| 42 | bile acid and bile salt transport (GO:0015721) | 4.79649409 |
| 43 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.69788801 |
| 44 | urea cycle (GO:0000050) | 4.69326905 |
| 45 | negative regulation of blood coagulation (GO:0030195) | 4.67586629 |
| 46 | negative regulation of hemostasis (GO:1900047) | 4.67586629 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.52816472 |
| 48 | ethanol metabolic process (GO:0006067) | 4.50144794 |
| 49 | tryptophan metabolic process (GO:0006568) | 4.42296375 |
| 50 | phospholipid efflux (GO:0033700) | 4.40038437 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 4.35269284 |
| 52 | protein activation cascade (GO:0072376) | 4.33298164 |
| 53 | flavonoid metabolic process (GO:0009812) | 4.29547440 |
| 54 | negative regulation of coagulation (GO:0050819) | 4.25354724 |
| 55 | intestinal cholesterol absorption (GO:0030299) | 4.22418583 |
| 56 | high-density lipoprotein particle remodeling (GO:0034375) | 4.20645121 |
| 57 | negative regulation of protein activation cascade (GO:2000258) | 4.16352929 |
| 58 | * acylglycerol homeostasis (GO:0055090) | 4.15781748 |
| 59 | * triglyceride homeostasis (GO:0070328) | 4.15781748 |
| 60 | negative regulation of wound healing (GO:0061045) | 4.12258491 |
| 61 | imidazole-containing compound metabolic process (GO:0052803) | 4.12243510 |
| 62 | arginine metabolic process (GO:0006525) | 4.08162626 |
| 63 | heme transport (GO:0015886) | 4.06230484 |
| 64 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.05511462 |
| 65 | amino acid salvage (GO:0043102) | 4.05050658 |
| 66 | L-methionine salvage (GO:0071267) | 4.05050658 |
| 67 | L-methionine biosynthetic process (GO:0071265) | 4.05050658 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.04692001 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 4.03188999 |
| 70 | protein-lipid complex remodeling (GO:0034368) | 4.03188999 |
| 71 | macromolecular complex remodeling (GO:0034367) | 4.03188999 |
| 72 | cholesterol efflux (GO:0033344) | 4.01696818 |
| 73 | positive regulation of hemostasis (GO:1900048) | 4.00884199 |
| 74 | positive regulation of blood coagulation (GO:0030194) | 4.00884199 |
| 75 | negative regulation of lipase activity (GO:0060192) | 3.98486764 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 3.92613027 |
| 77 | regulation of humoral immune response (GO:0002920) | 3.92584240 |
| 78 | complement activation, classical pathway (GO:0006958) | 3.90032004 |
| 79 | complement activation (GO:0006956) | 3.86263470 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.83956261 |
| 81 | acute-phase response (GO:0006953) | 3.83836074 |
| 82 | reverse cholesterol transport (GO:0043691) | 3.82935844 |
| 83 | positive regulation of coagulation (GO:0050820) | 3.70015193 |
| 84 | sodium-independent organic anion transport (GO:0043252) | 3.67961812 |
| 85 | xenobiotic metabolic process (GO:0006805) | 3.65828170 |
| 86 | drug transmembrane transport (GO:0006855) | 3.62236696 |
| 87 | kynurenine metabolic process (GO:0070189) | 3.61071880 |
| 88 | daunorubicin metabolic process (GO:0044597) | 3.58658906 |
| 89 | polyketide metabolic process (GO:0030638) | 3.58658906 |
| 90 | doxorubicin metabolic process (GO:0044598) | 3.58658906 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58057143 |
| 92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58057143 |
| 93 | response to mercury ion (GO:0046689) | 3.57932331 |
| 94 | ketone body metabolic process (GO:1902224) | 3.57031339 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 3.51975298 |
| 96 | negative regulation of complement activation (GO:0045916) | 3.49488624 |
| 97 | cellular biogenic amine catabolic process (GO:0042402) | 3.47235668 |
| 98 | amine catabolic process (GO:0009310) | 3.47235668 |
| 99 | regulation of cholesterol esterification (GO:0010872) | 3.45443711 |
| 100 | exogenous drug catabolic process (GO:0042738) | 10.4208896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.41755179 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.56796115 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.77022343 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.26383593 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.00078091 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.52331026 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.30445185 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.17766464 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.98536398 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.22364863 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16206882 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.10888898 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.09008727 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91651870 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.82976180 |
| 16 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.77337268 |
| 17 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.71372599 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61199843 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59400248 |
| 20 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.58651095 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 1.58389285 |
| 22 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53701488 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.53545591 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.53412852 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52001663 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.49610305 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.48608125 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47726733 |
| 29 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41245502 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.40933877 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34361281 |
| 32 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33781746 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32605292 |
| 34 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31710744 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30530986 |
| 36 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.26729837 |
| 37 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24701705 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23442505 |
| 39 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22836289 |
| 40 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22836289 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22613733 |
| 42 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22301562 |
| 43 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21353520 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20305910 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20044476 |
| 46 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19491557 |
| 47 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.17900596 |
| 48 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14812682 |
| 49 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13567332 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13216468 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13196928 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11799387 |
| 53 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11732253 |
| 54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11631285 |
| 55 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11626677 |
| 56 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.10968371 |
| 57 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10402178 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09071706 |
| 59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07698992 |
| 60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06764645 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06161829 |
| 62 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05766087 |
| 63 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05766087 |
| 64 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04303519 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03839105 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03614821 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03287110 |
| 68 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02628838 |
| 69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01596833 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01009545 |
| 71 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00841637 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00829869 |
| 73 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00360565 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00212880 |
| 75 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99071010 |
| 76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98694306 |
| 77 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98686248 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98106283 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98106283 |
| 80 | CBP_21632823_ChIP-Seq_H3396_Human | 0.98005567 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97318982 |
| 82 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96672927 |
| 83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.95801950 |
| 84 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95748178 |
| 85 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95047874 |
| 86 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.94927290 |
| 87 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.94802857 |
| 88 | NFYA_21822215_ChIP-Seq_K562_Human | 0.94701824 |
| 89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94533801 |
| 90 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.92621895 |
| 91 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.92621895 |
| 92 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.91970008 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91898567 |
| 94 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89821476 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88720831 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88515234 |
| 97 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88333192 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 0.88238059 |
| 99 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.88079154 |
| 100 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.86970634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.62967077 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.19262213 |
| 3 | MP0003195_calcinosis | 6.15838216 |
| 4 | MP0005365_abnormal_bile_salt | 5.75642606 |
| 5 | MP0005360_urolithiasis | 5.51005030 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.47614154 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.51992337 |
| 8 | MP0003252_abnormal_bile_duct | 4.38841288 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.18527619 |
| 10 | MP0003868_abnormal_feces_composition | 2.99526865 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.85788218 |
| 12 | MP0005332_abnormal_amino_acid | 2.42120668 |
| 13 | MP0009697_abnormal_copulation | 2.35102371 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.18822140 |
| 15 | MP0009840_abnormal_foam_cell | 1.94451060 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 1.85660553 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 1.67483743 |
| 18 | MP0000609_abnormal_liver_physiology | 1.66325838 |
| 19 | MP0001764_abnormal_homeostasis | 1.64532166 |
| 20 | MP0010368_abnormal_lymphatic_system | 1.37404450 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.28900830 |
| 22 | MP0005408_hypopigmentation | 1.16806390 |
| 23 | MP0005670_abnormal_white_adipose | 1.13233773 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.11681537 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.08138969 |
| 26 | MP0009053_abnormal_anal_canal | 1.04513893 |
| 27 | MP0008872_abnormal_physiological_respon | 1.02062657 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.01842037 |
| 29 | MP0001661_extended_life_span | 1.01229382 |
| 30 | MP0003879_abnormal_hair_cell | 0.98735566 |
| 31 | MP0003011_delayed_dark_adaptation | 0.97638367 |
| 32 | MP0002168_other_aberrant_phenotype | 0.92496342 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91898998 |
| 34 | MP0005395_other_phenotype | 0.90825090 |
| 35 | MP0000598_abnormal_liver_morphology | 0.88443573 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 0.87958663 |
| 37 | MP0009764_decreased_sensitivity_to | 0.85662185 |
| 38 | MP0005376_homeostasis/metabolism_phenot | 0.83019683 |
| 39 | MP0009642_abnormal_blood_homeostasis | 0.80732372 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 0.77376687 |
| 41 | MP0005187_abnormal_penis_morphology | 0.75766311 |
| 42 | MP0002971_abnormal_brown_adipose | 0.74265611 |
| 43 | MP0005266_abnormal_metabolism | 0.72092349 |
| 44 | MP0004043_abnormal_pH_regulation | 0.71179521 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 0.69837807 |
| 46 | MP0002132_abnormal_respiratory_system | 0.69139114 |
| 47 | MP0002928_abnormal_bile_duct | 0.66090275 |
| 48 | MP0005535_abnormal_body_temperature | 0.65989630 |
| 49 | MP0008469_abnormal_protein_level | 0.65230644 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.64261552 |
| 51 | MP0003186_abnormal_redox_activity | 0.63661671 |
| 52 | MP0003638_abnormal_response/metabolism_ | 0.63073916 |
| 53 | MP0009763_increased_sensitivity_to | 0.62750693 |
| 54 | MP0005646_abnormal_pituitary_gland | 0.60280713 |
| 55 | MP0003718_maternal_effect | 0.59524113 |
| 56 | MP0003690_abnormal_glial_cell | 0.59094920 |
| 57 | MP0003646_muscle_fatigue | 0.58268944 |
| 58 | MP0004142_abnormal_muscle_tone | 0.58036151 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 0.56512954 |
| 60 | MP0002282_abnormal_trachea_morphology | 0.56383145 |
| 61 | MP0003878_abnormal_ear_physiology | 0.54692204 |
| 62 | MP0005377_hearing/vestibular/ear_phenot | 0.54692204 |
| 63 | MP0001501_abnormal_sleep_pattern | 0.51968856 |
| 64 | MP0005448_abnormal_energy_balance | 0.51614031 |
| 65 | MP0001986_abnormal_taste_sensitivity | 0.50252278 |
| 66 | MP0005334_abnormal_fat_pad | 0.50147560 |
| 67 | MP0000604_amyloidosis | 0.48979366 |
| 68 | MP0001915_intracranial_hemorrhage | 0.48528542 |
| 69 | MP0005647_abnormal_sex_gland | 0.48170865 |
| 70 | MP0010386_abnormal_urinary_bladder | 0.47111809 |
| 71 | MP0001756_abnormal_urination | 0.46468456 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.44833295 |
| 73 | MP0004130_abnormal_muscle_cell | 0.43614294 |
| 74 | MP0005451_abnormal_body_composition | 0.41932771 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 0.41442620 |
| 76 | MP0002909_abnormal_adrenal_gland | 0.39791336 |
| 77 | MP0005464_abnormal_platelet_physiology | 0.38968679 |
| 78 | MP0003953_abnormal_hormone_level | 0.38843443 |
| 79 | MP0008874_decreased_physiological_sensi | 0.37343594 |
| 80 | MP0001984_abnormal_olfaction | 0.37145587 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.35840875 |
| 82 | MP0004883_abnormal_blood_vessel | 0.35403867 |
| 83 | MP0000639_abnormal_adrenal_gland | 0.35382656 |
| 84 | MP0009745_abnormal_behavioral_response | 0.34894096 |
| 85 | MP0003633_abnormal_nervous_system | 0.34732431 |
| 86 | MP0005386_behavior/neurological_phenoty | 0.33226584 |
| 87 | MP0004924_abnormal_behavior | 0.33226584 |
| 88 | MP0003632_abnormal_nervous_system | 0.31854625 |
| 89 | MP0000249_abnormal_blood_vessel | 0.30277005 |
| 90 | MP0000371_diluted_coat_color | 0.29985349 |
| 91 | MP0009115_abnormal_fat_cell | 0.29755601 |
| 92 | MP0003631_nervous_system_phenotype | 0.29540801 |
| 93 | MP0003959_abnormal_lean_body | 0.29386576 |
| 94 | MP0002249_abnormal_larynx_morphology | 0.28258937 |
| 95 | MP0002102_abnormal_ear_morphology | 0.28203484 |
| 96 | MP0005164_abnormal_response_to | 0.26811139 |
| 97 | MP0001944_abnormal_pancreas_morphology | 0.25300722 |
| 98 | MP0000569_abnormal_digit_pigmentation | 0.21475257 |
| 99 | MP0003045_fibrosis | 0.21196287 |
| 100 | MP0009785_altered_susceptibility_to | 0.21097287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.78527451 |
| 2 | Deep venous thrombosis (HP:0002625) | 9.12378892 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 8.76613869 |
| 4 | Complement deficiency (HP:0004431) | 7.97815226 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.88927206 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 7.65765877 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 6.60291653 |
| 8 | Abnormality of complement system (HP:0005339) | 6.24496610 |
| 9 | Joint hemorrhage (HP:0005261) | 5.91646294 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.63802729 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 5.38866179 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 5.01716884 |
| 13 | Xanthomatosis (HP:0000991) | 4.67714785 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.41518452 |
| 15 | Glomerulonephritis (HP:0000099) | 4.40065352 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.33454758 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.27650663 |
| 18 | Spontaneous abortion (HP:0005268) | 4.05032339 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.97401783 |
| 20 | Hyperglycinemia (HP:0002154) | 3.89389627 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.79509856 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.78364919 |
| 23 | Fat malabsorption (HP:0002630) | 3.55222224 |
| 24 | Nephritis (HP:0000123) | 3.49545067 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.43820435 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.43820435 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.36842230 |
| 28 | Hyperglycinuria (HP:0003108) | 3.35287063 |
| 29 | Generalized aminoaciduria (HP:0002909) | 3.28285009 |
| 30 | Rickets (HP:0002748) | 3.18676632 |
| 31 | Fair hair (HP:0002286) | 3.18044988 |
| 32 | Hyperammonemia (HP:0001987) | 3.06254118 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 3.04641037 |
| 34 | Delayed CNS myelination (HP:0002188) | 3.03828565 |
| 35 | Vascular calcification (HP:0004934) | 3.02540337 |
| 36 | Steatorrhea (HP:0002570) | 3.02320166 |
| 37 | Mitral stenosis (HP:0001718) | 2.99398885 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 2.85342419 |
| 39 | Epidermoid cyst (HP:0200040) | 2.77235407 |
| 40 | Gingival bleeding (HP:0000225) | 2.75091530 |
| 41 | Hypercholesterolemia (HP:0003124) | 2.71429113 |
| 42 | Osteomalacia (HP:0002749) | 2.66866543 |
| 43 | Hypoalphalipoproteinemia (HP:0003233) | 2.64713400 |
| 44 | Cardiovascular calcification (HP:0011915) | 2.63914654 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.60700747 |
| 46 | Hemorrhage of the eye (HP:0011885) | 2.52647825 |
| 47 | Abnormality of vitamin metabolism (HP:0100508) | 2.49744928 |
| 48 | Ketosis (HP:0001946) | 2.49126682 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 2.46136371 |
| 50 | Menorrhagia (HP:0000132) | 2.38067674 |
| 51 | Glycosuria (HP:0003076) | 2.35931285 |
| 52 | Abnormality of urine glucose concentration (HP:0011016) | 2.35931285 |
| 53 | Thrombophlebitis (HP:0004418) | 2.31344070 |
| 54 | Arthropathy (HP:0003040) | 2.31081609 |
| 55 | Abnormal biliary tract physiology (HP:0012439) | 2.29390599 |
| 56 | Bile duct proliferation (HP:0001408) | 2.29390599 |
| 57 | Hyperbilirubinemia (HP:0002904) | 2.28569999 |
| 58 | Hypochromic microcytic anemia (HP:0004840) | 2.27406532 |
| 59 | Metabolic acidosis (HP:0001942) | 2.26846264 |
| 60 | Hydroxyprolinuria (HP:0003080) | 2.26074492 |
| 61 | Abnormality of proline metabolism (HP:0010907) | 2.26074492 |
| 62 | Generalized hypopigmentation of hair (HP:0011358) | 2.25710023 |
| 63 | Pulmonary embolism (HP:0002204) | 2.25410622 |
| 64 | Hypophosphatemic rickets (HP:0004912) | 2.19985595 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.19598246 |
| 66 | Purpura (HP:0000979) | 2.19290018 |
| 67 | Bifid scrotum (HP:0000048) | 2.19145597 |
| 68 | Enlarged kidneys (HP:0000105) | 2.15007118 |
| 69 | Hyperphosphaturia (HP:0003109) | 2.13155656 |
| 70 | Reduced antithrombin III activity (HP:0001976) | 2.09720618 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.05600695 |
| 72 | Proximal tubulopathy (HP:0000114) | 2.03138772 |
| 73 | Poikilocytosis (HP:0004447) | 2.01514560 |
| 74 | Neonatal hypoglycemia (HP:0001998) | 1.87277345 |
| 75 | Alkalosis (HP:0001948) | 1.85675010 |
| 76 | Irritability (HP:0000737) | 1.85210452 |
| 77 | Ketoacidosis (HP:0001993) | 1.78836057 |
| 78 | Increased mean platelet volume (HP:0011877) | 1.72940094 |
| 79 | Hypochromic anemia (HP:0001931) | 1.72739284 |
| 80 | Gangrene (HP:0100758) | 1.72219885 |
| 81 | Lethargy (HP:0001254) | 1.71388704 |
| 82 | Joint swelling (HP:0001386) | 1.71013631 |
| 83 | Potter facies (HP:0002009) | 1.69613551 |
| 84 | Facial shape deformation (HP:0011334) | 1.69613551 |
| 85 | Blue irides (HP:0000635) | 1.69384344 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.61620382 |
| 87 | Abnormal urine phosphate concentration (HP:0012599) | 1.61076560 |
| 88 | Hyperventilation (HP:0002883) | 1.60958980 |
| 89 | Cerebral palsy (HP:0100021) | 1.58229219 |
| 90 | Myocardial infarction (HP:0001658) | 1.57268434 |
| 91 | Abnormality of purine metabolism (HP:0004352) | 1.56586251 |
| 92 | Hypoglycemic coma (HP:0001325) | 1.55979741 |
| 93 | Decreased central vision (HP:0007663) | 1.52146378 |
| 94 | Submucous cleft hard palate (HP:0000176) | 1.52061651 |
| 95 | Retinal atrophy (HP:0001105) | 1.50194684 |
| 96 | Renal cortical cysts (HP:0000803) | 1.49426119 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 1.48816868 |
| 98 | Abnormal platelet volume (HP:0011876) | 1.48715589 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 1.48655686 |
| 100 | Pancreatitis (HP:0001733) | 1.48096898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 8.32515352 |
| 2 | PIK3CG | 3.08105386 |
| 3 | WNK3 | 2.93781099 |
| 4 | NTRK3 | 2.69502731 |
| 5 | ACVR1B | 2.57048977 |
| 6 | PINK1 | 2.41312698 |
| 7 | INSRR | 2.23543352 |
| 8 | BMPR1B | 2.06990621 |
| 9 | PIK3CA | 2.01567555 |
| 10 | TAOK3 | 2.01398530 |
| 11 | ADRBK2 | 1.98576832 |
| 12 | GRK1 | 1.83805098 |
| 13 | MAP4K2 | 1.79486700 |
| 14 | CASK | 1.73311231 |
| 15 | STK38L | 1.69128970 |
| 16 | PRKAA2 | 1.68250740 |
| 17 | PRKCG | 1.54379500 |
| 18 | FER | 1.42008779 |
| 19 | BCKDK | 1.39605109 |
| 20 | EPHA3 | 1.37187566 |
| 21 | CAMKK2 | 1.33202460 |
| 22 | PRKACG | 1.28857674 |
| 23 | TNK2 | 1.28587530 |
| 24 | NLK | 1.27244646 |
| 25 | DAPK2 | 1.26120164 |
| 26 | EPHA4 | 1.17861222 |
| 27 | OXSR1 | 1.13938320 |
| 28 | MAPK13 | 1.10914160 |
| 29 | NUAK1 | 1.09597054 |
| 30 | FGFR2 | 1.05935009 |
| 31 | MAPK11 | 1.05443007 |
| 32 | IGF1R | 1.00740230 |
| 33 | AKT3 | 1.00736736 |
| 34 | ZAK | 1.00340018 |
| 35 | PRKCE | 1.00261466 |
| 36 | MAP3K4 | 0.97301671 |
| 37 | SGK2 | 0.96935850 |
| 38 | ERBB2 | 0.95508678 |
| 39 | FGFR3 | 0.95392740 |
| 40 | ERN1 | 0.95209952 |
| 41 | WNK4 | 0.94486293 |
| 42 | PRKAA1 | 0.93612015 |
| 43 | PAK3 | 0.93523472 |
| 44 | BCR | 0.92849177 |
| 45 | STK39 | 0.92537785 |
| 46 | LATS1 | 0.92382577 |
| 47 | MAPKAPK3 | 0.88875444 |
| 48 | FGFR4 | 0.86975281 |
| 49 | MAP2K4 | 0.85923242 |
| 50 | PRKCZ | 0.85092975 |
| 51 | TYK2 | 0.83272871 |
| 52 | ADRBK1 | 0.77490527 |
| 53 | PRKACA | 0.77320391 |
| 54 | SGK223 | 0.75424408 |
| 55 | SGK494 | 0.75424408 |
| 56 | STK38 | 0.74409152 |
| 57 | BRSK2 | 0.72325292 |
| 58 | TNIK | 0.68568054 |
| 59 | PRKG1 | 0.67743788 |
| 60 | CSNK1D | 0.66893017 |
| 61 | MAP3K7 | 0.64476230 |
| 62 | IRAK1 | 0.56215181 |
| 63 | CAMK1D | 0.55605077 |
| 64 | TIE1 | 0.54458679 |
| 65 | TXK | 0.54327855 |
| 66 | PRKCB | 0.53208462 |
| 67 | PRKCA | 0.53201885 |
| 68 | MAP3K2 | 0.51445661 |
| 69 | PDK2 | 0.51321708 |
| 70 | MAP2K6 | 0.50186311 |
| 71 | MKNK2 | 0.50175257 |
| 72 | MUSK | 0.49964107 |
| 73 | SGK1 | 0.49760571 |
| 74 | SGK3 | 0.49585273 |
| 75 | CSNK1A1 | 0.47389162 |
| 76 | PRKCQ | 0.47174164 |
| 77 | CAMK4 | 0.45399798 |
| 78 | EIF2AK3 | 0.45281069 |
| 79 | MAP2K7 | 0.44837622 |
| 80 | PRKACB | 0.44721241 |
| 81 | JAK1 | 0.44468331 |
| 82 | KIT | 0.43419827 |
| 83 | DYRK1A | 0.43109484 |
| 84 | CSF1R | 0.42771846 |
| 85 | TRPM7 | 0.42452473 |
| 86 | MYLK | 0.41649751 |
| 87 | CAMK1G | 0.40958566 |
| 88 | RPS6KA3 | 0.40522308 |
| 89 | PDPK1 | 0.39962718 |
| 90 | PDK1 | 0.39393840 |
| 91 | CSNK1G1 | 0.38963157 |
| 92 | MARK1 | 0.38639027 |
| 93 | IKBKB | 0.37300686 |
| 94 | ABL2 | 0.36976669 |
| 95 | TEC | 0.35949671 |
| 96 | CHUK | 0.35157836 |
| 97 | OBSCN | 0.33551302 |
| 98 | STK11 | 0.32259857 |
| 99 | ERBB3 | 0.31333150 |
| 100 | PTK2B | 0.31193245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.77319332 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.02606971 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.76262201 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.58450520 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.48008169 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.44974896 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.42639440 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.96296531 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.92164577 |
| 10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.74258066 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.67108426 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.58305528 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52201215 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37839851 |
| 15 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.28120766 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.24071815 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.13188247 |
| 18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.08330521 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.06267805 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.97708575 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.95981896 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90095581 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.79862114 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76566273 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.70869981 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49598237 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.44531577 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44008672 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43725554 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42752169 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.38645918 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.36962889 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33145543 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27732559 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21983875 |
| 36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21889333 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16413719 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13924615 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10247088 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.09473545 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08726220 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07257441 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93100921 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92777055 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91872579 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.88550215 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87449168 |
| 48 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79288803 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74097740 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 0.67604991 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67321868 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60531778 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56421052 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52459658 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.49538363 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45551493 |
| 57 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44728018 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44380450 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39480597 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35362121 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31807206 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.25103984 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24829353 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23873131 |
| 65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23518540 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.22772145 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.20490050 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.16985171 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.16187112 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.15909220 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.12522898 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.12391377 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08420325 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06411143 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.06161811 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06042441 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02387670 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.00430790 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.00193147 |
| 80 | Nicotine addiction_Homo sapiens_hsa05033 | -0.1750235 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1692508 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1611307 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.1593589 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1517756 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.1397449 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1346228 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1152684 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1120433 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1095475 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1018288 |
| 91 | Phototransduction_Homo sapiens_hsa04744 | -0.0902415 |
| 92 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0783080 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0702438 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0640214 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0537869 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0433276 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | -0.0397156 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0363296 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0178906 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | -0.0147772 |

